Skip to main content
Erschienen in: Trials 1/2020

Open Access 22.06.2020 | COVID-19 | Letter

Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial

verfasst von: J. P. Desilles, C. Gregoire, C. Le Cossec, J. Lambert, O. Mophawe, M. R. Losser, F. Lambiotte, S. Le Tacon, M. Cantier, N. Engrand, P. Trouiller, J. Pottecher

Erschienen in: Trials | Ausgabe 1/2020

download
DOWNLOAD
print
DRUCKEN
Metadaten
Titel
Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial
verfasst von
J. P. Desilles
C. Gregoire
C. Le Cossec
J. Lambert
O. Mophawe
M. R. Losser
F. Lambiotte
S. Le Tacon
M. Cantier
N. Engrand
P. Trouiller
J. Pottecher
Publikationsdatum
22.06.2020
Verlag
BioMed Central
Schlagwort
COVID-19
Erschienen in
Trials / Ausgabe 1/2020
Elektronische ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-04488-8

Weitere Artikel der Ausgabe 1/2020

Trials 1/2020 Zur Ausgabe